Gene-Edited Pig Kidney Transplant Sets 285-Day Survival Record

This milestone extends the observable envelope for xenotransplantation efficacy, moving the field beyond the earlier 271-day benchmark and suggesting that gene-edited organs can sustain function over a clinically meaningful timeframe. The significance lies not in the raw number but in what it implies for the durability of immune compatibility and organ integration, which are the core hurdles for scaling this approach. For patients awaiting human donors, this lengthening track record strengthens the case that xenotransplants could serve as a bridge or alternative, though the single-patient nature of the data limits broad conclusions. The open question is whether this survival trajectory holds without complications that emerged in prior cases, and how it translates to broader clinical trials.